<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
  xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
  xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://researchpepnews.com/articles/glow-klow-wolverine-peptide-compounding-policy</loc>
    <news:news>
      <news:publication>
        <news:name>Research Pep News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29</news:publication_date>
      <news:title>GLOW, KLOW and Wolverine: What the New Peptide Compounding Policy Leaves Out</news:title>
    </news:news>
    <image:image>
      <image:loc>https://researchpepnews.com/images/editorial/hims-oral-compounding-pharmacist.webp</image:loc>
      <image:caption>A pharmacy worker in gloves and a hair covering reviews paperwork while holding an amber medicine bottle beside a laboratory balance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://researchpepnews.com/articles/retatrutide-vs-ozempic-transcend-t2d-2</loc>
    <news:news>
      <news:publication>
        <news:name>Research Pep News</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29</news:publication_date>
      <news:title>Retatrutide vs. Ozempic: Inside the New Head-to-Head Trial</news:title>
    </news:news>
    <image:image>
      <image:loc>https://researchpepnews.com/images/editorial/retatrutide-regulatory-pathway.png</image:loc>
      <image:caption>A molecular model between two document binders, beside a magnifying glass and research papers.</image:caption>
    </image:image>
  </url>
</urlset>